WASHINGTON, Sept. 24 -- Food and Drug Administration has issued a notice called: Improving Patient Access to Deceased Donor Islet Cells and Cell Products; Request for Information.
The notice was published in the Federal Register on Sept. 24 by Robert F. Kennedy, Secretary, Department of Health and Human Services.
Summary: The Department of Health and Human Services (HHS) is opening a public docket to solicit input, supporting data, and comments to assist HHS as it considers how best to regulate deceased donor islet cells and/or deceased donor islet cell products for the treatment of Type 1 diabetes (T1D). The purpose of this information is to allow HHS agencies to better understand how best to regulate these therapies, including whether a...